Akers Biosciences Inc (AKER) to Release Quarterly Earnings on Monday
Akers Biosciences (NASDAQ:AKER) last announced its quarterly earnings data on Monday, August 14th. The medical instruments supplier reported ($0.08) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by ($0.04). The business had revenue of $1.20 million during the quarter. Akers Biosciences had a negative return on equity of 59.94% and a negative net margin of 89.49%.
Akers Biosciences Inc (NASDAQ:AKER) opened at $0.73 on Friday. Akers Biosciences Inc has a 1 year low of $0.68 and a 1 year high of $3.55.
About Akers Biosciences
Akers Biosciences, Inc, together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States and internationally. The companys marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor ketosis; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness.
Receive News & Stock Ratings for Akers Biosciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akers Biosciences Inc and related stocks with our FREE daily email newsletter.